Penn researchers aim to uncover the underlying biological mechanisms of TBI-related neurodegeneration

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 42 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 44%
  • Publisher: 71%

Alzheimer's Disease News

Brain,Hospital,Imaging

A team of researchers led by Penn Medicine will investigate the link between traumatic brain injuries (TBI) and Alzheimer's disease and related dementias (ADRD) over the next five years with a $10 million grant from the National Institute of Neurological Disorders and Stroke (NINDS).

University of Pennsylvania School of MedicineJun 28 2024 A team of researchers led by Penn Medicine will investigate the link between traumatic brain injuries and Alzheimer's disease and related dementias over the next five years with a $10 million grant from the National Institute of Neurological Disorders and Stroke .

The team of 26 investigators across 12 sites aims to uncover the type and extent of neuropathological changes that emerge after TBI. They will evaluate the pathologies from a variety of types of TBI which could range from a single, severe injury, like from a car accident, to mild, repetitive injuries, which can occur while playing a contact sport. The team will also look at TBI, that results from military combat and intimate partner violence.

TRANSFORM-TBI is the second phase of research to study TReND. In 2019, Smith, Lee and Willie Stewart of the University of Glasgow, UK, established CONNECT-TBI-;a program spanning 12 institutions to establish diagnostic criteria for TReND. To date, CONNECT-TBI has gathered clinical datasets and tissue archives from over 1,000 cases across participating centers.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Insilico Medicine leadership team shares insights on AI-powered healthcare innovationInsilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announces that the co-CEOs of the company – Alex Zhavoronkov, PhD, and Feng Ren, PhD – will be attending the 15th Annual Meeting of the New Champions, also known as Summer Davos hosted by the World Economic Forum, in Dalian,...
Source: NewsMedical - 🏆 19. / 71 Read more »

Research finds causal evidence tying cerebral small-vessel disease to Alzheimer’s, dementiaResearch led by in part by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) finds that the most common cerebral small-vessel disease feature seen in brain magnetic resonance imaging is a primary vascular factor associated with dementia risk.
Source: NewsMedical - 🏆 19. / 71 Read more »

New genetic clue in understanding increased Alzheimer's riskScientists have discovered a new piece of the puzzle in understanding why some people are more susceptible to Alzheimer's disease. The research has been published in the journal Nature Communications.
Source: medical_xpress - 🏆 101. / 51 Read more »

Study finds causal evidence tying cerebral small-vessel disease to Alzheimer's and dementiaResearch led in part by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) finds that the most common cerebral small-vessel disease feature seen in brain magnetic resonance imaging is a primary vascular factor associated with dementia risk.
Source: medical_xpress - 🏆 101. / 51 Read more »